Transform Chronic Disease Management with Value-Based Healthcare
At the UCLA Health Center for Inflammatory Bowel Diseases, I helped the team to pioneer a value-based healthcare vision for the management of chronic diseases such as ulcerative colitis and Crohn’s disease. Our model for value-based healthcare brings together all stakeholders from patients to healthcare professionals, and researchers to payers to improve health outcomes. The success of our value quotient™ and tight controlled services is now inspiring the UCLA healthcare system to transform the management of other chronic diseases and cancer. Please learn more about our strategy and vision by watching the videos and images above. Below you’ll find some helpful links to the center website, social media channels and the 2012 key performance report. Needless to say there’s much more to share about this revolution in healthcare. Let us all embark on a journey to transform the management of chronic diseases and cancer.
I am pleased to highly recommend Michèle van der Kemp for her abilities in the field of value-based health care. I have come to know Michèle during our collaborative work on the design of a translational health care platform (CuraRata) at the Leiden University Medical Center (2008 – 2011) and her assistance during the design of a value based health care model at the Center for Inflammatory Bowel Diseases, UCLA, Los Angeles (2011 – 2013).
Michèle is a strong and warm personality who positively influenced the creative and strategic processes of our various projects. On one hand she is able to help clearly express our vision and mission while on the other hand she is very accurate to the tiniest detail on an operational level. It is such a pleasure, not only for me but for entire teams, to follow the reasonable but strict timelines and see our projects blossom under her supervision. Of particular note are her positive attitude and sense of humor during oftentimes challenging moments.
With her relentless motivation and her knowledge of strategy and marketing aspects of this new form of health care, Michèle will in future undoubtedly contribute further to the field.
Daniel W. Hommes, MD PhD Professor of Medicine, Director of the Center for Inflammatory Bowel Diseases at UCLA Health, Los Angeles, California